The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A first-in-class ex vivo combination between cytokine-induced memory like (CIML) NK cells and a CD38 targeting antibody recruiting molecule (ARM) as a novel approach to target NK cells without cellular engineering for the treatment of multiple myeloma.
 
Luca Rastelli
Employment - Kleo Pharmaceuticals
Stock and Other Ownership Interests - Kleo Pharmaceuticals
 
Maqbool Mohsin
No Relationships to Disclose
 
Ann Marie Rossi
Employment - Kleo Pharmaceuticals
Stock and Other Ownership Interests - Kleo Pharmaceuticals
 
Enrique Alvarez Sotomayor
Employment - Kleo Pharmaceuticals
Stock and Other Ownership Interests - Kleo Pharmaceuticals
 
Lawrence Iben
Employment - Kleo Pharmaceuticals
Stock and Other Ownership Interests - Kleo Pharmaceuticals
 
Ada Vaill
Employment - Kleo Pharmaceuticals
Stock and Other Ownership Interests - Kleo Pharmaceuticals
 
Matthew Welsch
No Relationships to Disclose
 
Rizwan Romee
No Relationships to Disclose
 
Anna Bunin
Employment - Kleo Pharmaceuticals
Stock and Other Ownership Interests - Kleo Pharmaceuticals